Our study aimed at investigating how LINC01133 functions in gastric cancer (GC) progression. Gain-of-function and loss-of-function approaches were applied to analyze the effects of LINC01133, microRNA-576-5p (miR-576-5p) and somatostatin (SST) on the biological behaviors of GC cells and in tumor-bearing nude mice. GC tissues and cells showed low expression of LINC01133, and LINC01133 overexpression decreased malignant phenotypes of GC cells. Moreover, LINC01133 upregulated SST through binding to miR-576-5p. Overexpressing miR-576-5p or suppressing SST reversed the functions of LINC01133 in biological potentials of GC cells and tumor growth. LINC01133 overexpression may inhibit GC development by downregulation of miR-576-5p and upregulation of SST, which suggests new therapeutic targets for GC.

Download full-text PDF

Source
http://dx.doi.org/10.2217/epi-2020-0377DOI Listing

Publication Analysis

Top Keywords

linc01133
8
gastric cancer
8
linc01133 overexpression
8
linc01133 hampers
4
hampers development
4
development gastric
4
cancer increasing
4
increasing somatostatin via
4
somatostatin via binding
4
binding microrna-576-5p
4

Similar Publications

Article Synopsis
  • LINC01133 is a long non-coding RNA (lncRNA) that plays crucial roles in cancer, with this study focusing on its expression and impact in laryngeal squamous cell carcinoma (LSCC).
  • Integrative analysis of genetic data revealed LINC01133 is significantly downregulated in LSCC compared to normal tissues, and lower levels are linked to advanced tumor stages and lymph node metastasis.
  • The study suggests that LINC01133 may act as a tumor suppressor by disrupting microRNA interactions, indicating its potential diagnostic and therapeutic importance in LSCC.
View Article and Find Full Text PDF

Background: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) are currently 2 major diagnostic biomarkers for gastric cancer (GC). The aims of study were to detect the expression of long intergenic nonprotein coding RNA 1133 (LINC01133), and to evaluate its diagnostic and prognostic value in GC. Furthermore, the clinical performance of the joint detection of LINC01133, CEA and CA19-9 was also evaluate in GC.

View Article and Find Full Text PDF
Article Synopsis
  • Osteoporosis is linked to reduced bone mass, and the study focuses on the role of LINC01133 in promoting the differentiation of human bone marrow mesenchymal stem cells (hBMSCs) into bone-forming cells.
  • Researchers analyzed the expression of LINC01133 and related genes in osteoporosis patients and found that lower levels of LINC01133 and CTNNB1 correspond to the condition, while their levels rise during osteogenic differentiation in hBMSCs.
  • The study suggests that LINC01133 helps regulate CTNNB1 by inhibiting miR-214-3p, which supports bone formation and offers insights that could aid in developing treatments for osteoporosis.
View Article and Find Full Text PDF

Wound healing in diabetic ulcers remains a significant clinical challenge, primarily due to bacterial infection and impaired angiogenesis. Periplaneta americana extract (PAE) has been widely used to treat diabetic wounds, yet its underlying mechanisms are not fully understood. This study aimed to elucidate these mechanisms by analyzing long non-coding RNA (lncRNA) expressions in the wound tissues from diabetic anal fistula patients treated with or without PAE, using high-throughput sequencing.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with limited treatment methods. Long non-coding RNAs (lncRNAs) have been found involved in tumorigenic and progression. The present study revealed that LINC01133, a fewly reported lncRNA, was one of 16 hub genes that could predict PDAC patients' prognosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!